当前位置:首页 - 行情中心 - 以岭药业(002603) - 财务分析 - 现金流量表

以岭药业

(002603)

  

流通市值:230.90亿  总市值:280.18亿
流通股本:13.77亿   总股本:16.71亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,096,951,718.032,035,275,225.737,374,426,224.75,435,884,614.79
  收到的税费返还10,983,581.726,990,272.2247,073,709.9539,663,227.37
  收到其他与经营活动有关的现金194,952,597.89138,584,150.96158,373,979.78124,813,345.15
  经营活动现金流入小计4,302,887,897.642,180,849,648.917,579,873,914.435,600,361,187.31
  购买商品、接受劳务支付的现金1,399,269,183.84677,161,326.982,567,642,112.511,866,156,485.51
  支付给职工以及为职工支付的现金890,874,125.06503,019,539.82,028,935,181.761,512,959,002.78
  支付的各项税费436,449,671.81251,072,394.8758,333,319.3608,957,017.9
  支付其他与经营活动有关的现金744,254,840.97409,499,279.921,613,950,129.751,289,658,850.04
  经营活动现金流出小计3,470,847,821.681,840,752,541.56,968,860,743.325,277,731,356.23
  经营活动产生的现金流量净额832,040,075.96340,097,107.41611,013,171.11322,629,831.08
二、投资活动产生的现金流量:
  收回投资收到的现金793,000,000280,000,0004,038,400,0002,133,000,000
  取得投资收益收到的现金1,159,120.01127,334.14117,404,565.0113,336,173.44
  处置固定资产、无形资产和其他长期资产收回的现金净额41,637.17-20,062.6218,062.62
  投资活动现金流入小计794,200,757.18280,127,334.144,155,824,627.632,146,354,236.06
  购建固定资产、无形资产和其他长期资产支付的现金87,657,764.7638,707,141.73290,390,861.8234,069,910.38
  投资支付的现金1,353,500,000439,800,0002,253,400,0001,912,400,000
  投资活动现金流出小计1,441,157,764.76478,507,141.732,543,790,861.82,146,469,910.38
  投资活动产生的现金流量净额-646,957,007.58-198,379,807.591,612,033,765.83-115,674.32
三、筹资活动产生的现金流量:
  取得借款收到的现金--870,000,000770,000,000
  收到其他与筹资活动有关的现金--312,500,000277,716,733.33
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--1,182,500,0001,047,716,733.33
  偿还债务支付的现金--2,269,700,000902,969,000
  分配股利、利润或偿付利息支付的现金--375,305,427.14249,789,487.71
  支付其他与筹资活动有关的现金5,423,118.14293,760790,677,738.58202,847,275.65
  筹资活动现金流出小计5,423,118.14293,7603,435,683,165.721,355,605,763.36
  筹资活动产生的现金流量净额-5,423,118.14-293,760-2,253,183,165.72-307,889,030.03
四、汇率变动对现金及现金等价物的影响143,861.5181,373.65105,273.7-19,813.01
五、现金及现金等价物净增加额179,803,811.75141,504,913.47-30,030,955.0814,605,313.72
  加:期初现金及现金等价物余额816,603,174.4816,603,174.4846,634,129.48846,634,129.48
  期末现金及现金等价物余额996,406,986.15958,108,087.87816,603,174.4861,239,443.2
补充资料:
  净利润665,298,290.44--734,183,532.26-
  资产减值准备22,155,438.01-258,634,321.14-
  固定资产和投资性房地产折旧283,598,507.86-567,258,960.64-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧283,598,507.86-567,258,960.64-
  无形资产摊销14,285,571.65-34,183,590.66-
  长期待摊费用摊销1,261,525.8-2,503,572.5-
  处置固定资产、无形资产和其他长期资产的损失-14,191.17-487,181.84-
  固定资产报废损失--662,733.38-
  财务费用401,838.23-27,551,220.67-
  投资损失-1,153,911.22--44,866,293.04-
  递延所得税56,494,805.31--198,147,018.29-
  其中:递延所得税资产减少58,355,936.27--182,256,954.56-
    递延所得税负债增加-1,861,130.96--15,890,063.73-
  存货的减少259,403,092.16-470,315,349.57-
  经营性应收项目的减少-437,072,295.63-638,252,197.66-
  经营性应付项目的增加-36,252,562.16--447,299,507.65-
  其他--25,550,920.26-
  现金的期末余额996,406,986.15-816,603,174.4-
  减:现金的期初余额816,603,174.4-846,634,129.48-
  现金及现金等价物的净增加额179,803,811.75--30,030,955.08-
公告日期2025-08-282025-04-292025-04-292024-10-29
审计意见(境内)标准无保留意见
TOP↑